Relevium Reports $250,000 in Pre-Sales for Bioganix® CleanCare Hand Sanitizers in First 6 Days Pharmaceutical Investing
Revive Therapeutics Announces Closing of Second Tranche of Brokered Private Placement Pharmaceutical Investing
Algernon Receives Positive Feedback from U.S. FDA for New Ifenprodil Intravenous Formulation Pharmaceutical Investing
Cardiol Announces Study Demonstrating Its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart Pharmaceutical Investing
Relevium To Launch Photocatalytic UV Air Purification System For Bioganix® Cleancare Line Pharmaceutical Investing
Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board Pharmaceutical Investing
Relevium Launches Pre-order of Bioganix® Cleancare Hand Sanitizers in Canada and Usa Pharmaceutical Investing
Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea Pharmaceutical Investing
Relevium Secures NPN Number With Manufacturing Partner And Is Ready To Market Bioganix® Cleancare Hand Sanitizers In Canada Pharmaceutical Investing
Revive Therapeutics Engages Novotech as Asia-Pacific CRO for Bucillamine in the Treatment of Infectious Diseases Pharmaceutical Investing
Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial Pharmaceutical Investing
